SCHEMBL11306357

SCHEMBL11306357

CC(C)Oc1ccc(N(c2ccc(C(=O)NO)cc2)C2CCNC2=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.46
▸ MAPT P10636 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ RAB9A P51151 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ LMNA P02545 2/20 0.46
▸ TP53 P04637 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ KDM4E B2RXH2 1/20 0.46
▸ MCL1 Q07820 1/20 0.46
▸ NFKB1 P19838 1/20 0.42
▸ NFKB2 Q00653 1/20 0.42
▸ RELA Q04206 1/20 0.42
▸ POLB P06746 1/20 0.42
▸ TDP1 Q9NUW8 2/20 0.41
▸ ALOX15 P16050 2/20 0.41
▸ GFER P55789 1/20 0.41
▸ ADAM17 P78536 1/20 0.41
▸ HDAC3 O15379 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11297369 0.91 HDAC6 (0.40) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11299083 0.85 HDAC6 (0.42) NPC1RAB9ASMN1; SMN2HDAC3HDAC1
SCHEMBL11297519 0.83 HDAC6 (0.43) ALDH1A1NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL11301754 0.82 PSEN1 (0.42) ALDH1A1POLBTDP1HDAC1HDAC2
SCHEMBL11305647 0.82 HDAC6 (0.41) NPC1RAB9ALMNAKDM4EALOX15
SCHEMBL11297375 0.81 HDAC8 (0.44) NPC1LMNAKDM4EALOX15ADAM17
SCHEMBL11301397 0.80 HDAC1 (0.39) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL11297424 0.80 HDAC1 (0.43) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL11296107 0.80 HDAC8 (0.45) RAB9AHDAC3HDAC1HDAC8HDAC6
SCHEMBL11296049 0.80 HDAC6 (0.45) ALDH1A1NPC1RAB9ALMNAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP claimed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO claimed
EP-2665706-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F.HOFFMANN-LA ROCHE AG (CH) 2013-11-27 — — EP disclosed
WO-2012098132-A1 NOVEL 4-AMINO-N-HYDROXY-BENZAMIDES AS HDAC INHIBITORS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2012-07-26 — — WO disclosed
Send feedback